NIOX Group (LON:NIOX) Posts Earnings Results

NIOX Group (LON:NIOX) announced its quarterly earnings results on Wednesday. The company reported GBX 1.41 earnings per share for the quarter, Digital Look Earnings reports. NIOX Group had a return on equity of 10.14% and a net margin of 14.37%.

NIOX Group Price Performance

LON NIOX traded up GBX 0.40 during trading hours on Wednesday, reaching GBX 68.40. The company’s stock had a trading volume of 561,444 shares, compared to its average volume of 802,703. The company has a debt-to-equity ratio of 1.36, a quick ratio of 1.94 and a current ratio of 3.81. The company’s 50-day moving average is GBX 65.54 and its two-hundred day moving average is GBX 61.58. NIOX Group has a fifty-two week low of GBX 53.84 and a fifty-two week high of GBX 76. The stock has a market cap of £287.87 million, a PE ratio of 41.71 and a beta of 0.92.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.